Already running one of the largest ophthalmology practices in the country, Henry Ford Health System announced last week that it has agreed to merge with the Detroit Institute of Ophthalmology (DIO).
The mission of DIO has been two-pronged, officials say: to assist the visually impaired, with the goal of helping them maintain their independence, and to be a leader in advancing international collaboration and vision-related research. Under the terms of the merger DIO will become the research and education division of the Henry Ford's Department of Ophthalmology.
"Bringing our organizations together will give us greater ability to impact visual science through research," said Paul Edwards, MD, chair of ophthalmology at Henry Ford, in a press release. "It also means we'll be able to expand DIO support services for the visually impaired and blind, in collaboration with the Henry Ford Center for Visual Rehabilitation and Research."
The Henry Ford Department of Ophthalmology has 12 locations in southeast Michigan where it treats more than 55,000 patients annually. In addition, the Henry Ford Center for Vision Rehabilitation & Research’s two locations in Grosse Pointe Park and Livonia provide comprehensive rehabilitation to help people with macular degeneration and other low-vision conditions.
The DIO produces two international research events. "The Eye and The Chip" brings internationally renowned scientists to Detroit to discuss advancements in artificial vision, and "The Eye and The Auto," produced in alternate years, addresses issues related to vision and safe driving.
"Integration of our programs and events into the Henry Ford Department of Ophthalmology assures our volunteers, our donors, and our staff, of a healthy and wise succession," said Philip Hessburg, MD, director of the DIO, in a prepared statement announcing the planned merger.